122Certificate evidence of presence of a prohibited drug

122 Certificate evidence of presence of a prohibited drug

122 Certificate evidence of presence of a prohibited drug

(1) For the purposes of any disciplinary procedure involving a prohibited drug contravention, a certificate purporting to be signed by a medical practitioner or registered nurse and certifying any one or more of the following matters—

(a) that the practitioner or nurse was a medical practitioner or registered nurse who attended a specified person at a hospital,

(b) that the practitioner or nurse took a sample of the juvenile justice officer’s blood or was provided with or took a non-invasive sample from the officer in accordance with Division 2 of Part 4A of the Act and this Part on the day and at the time stated in the certificate,

(c) that the practitioner or nurse dealt with the sample in accordance with clause 116 or 117,

is prima facie evidence of the particulars certified in and by the certificate.

(2) For the purposes of any disciplinary procedure involving a prohibited drug contravention, a certificate purporting to be signed by a person and certifying any one or more of the following matters—

(a) that the person was provided with or took a non-invasive sample from a specified person in accordance with Division 2 of Part 4A of the Act and this Part on the day and at the time stated in the certificate,

(b) that the person dealt with the sample in accordance with clause 117,

is prima facie evidence of the particulars certified in and by the certificate.

(3) For the purposes of any disciplinary procedure involving a prohibited drug contravention, a certificate purporting to be signed by a government analyst and certifying any one or more of the following matters—

(a) that the analyst received, on a specified day, a portion of a sample of a specified person’s blood or a non-invasive sample provided by or taken from a specified person in a container submitted for analysis under Division 2 of Part 4A of the Act and this Part,

(b) that the container, as received by the analyst, was sealed, and marked or labelled, in a specified manner,

(c) that, on receipt by the analyst of the container, the seal was unbroken,

(d) that the analyst carried out an analysis of the portion to determine whether any prohibited drug was present in the sample,